| 1 |
Hsieh TC, Wu JM. Resveratrol: Biological and pharmaceutical properties as anticancer molecule[J]. Biofactors, 2010, 36: 360-369.
|
| 2 |
Schnekenburger M, Dicato M, Diederich M. Plant-derived epigenetic modulators for cancer treatment and prevention[J]. Biotechnol Adv, 2014, 32: 1123-1132.
|
| 3 |
Chan S, Kantham S, Rao VM, et al. Metal chelation, radical scavenging and inhibition of Aβ42 fibrillation by food constituents in relation to Alzheimer's disease[J]. Food Chem, 2016, 199: 185-194.
|
| 4 |
Blanquer-Rosselló MD, Hernández-López R, Roca P, et al. Resveratrol induces mitochondrial respiration and apoptosis in SW620 colon cancer cells[J]. Biochim Biophys Acta, 2017, 861: 431-440.
|
| 5 |
Kundu JK, Surh YJ. Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives[J]. Cancer Lett, 2008, 269: 243-261.
|
| 6 |
Athar M, Back JH, Kopelovich L, et al. Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms[J]. Arch Biochem Biophys, 2009, 486: 95-102.
|
| 7 |
Goswami SK, Das DK. Resveratrol and chemoprevention[J]. Cancer Lett, 2009, 284: 1-6.
|
| 8 |
Dang CV. MYC on the path to cancer[J]. Cell, 2012, 149(1): 22-35.
|
| 9 |
Beroukhim R, Mermel CH, Porter D, et al. The landscape of somatic copy-number alteration across human cancers[J]. Nature, 2010, 463(7283): 899-905.
|
| 10 |
Chen H, Liu H, Qing G. Targeting oncogenic Myc as a strategy for cancer treatment[J]. Signal Transduct Target Ther, 2018, 3(1): 5.
|
| 11 |
Wangping Li, Yun Shi, Ruixuan Wang, et al. Resveratrol promotes the sensitivity of small cell lung cancer H446 cell lines to cisplatin via mitochondrial apoptotic pathway[J]. Int J Oncol, 2018, 53: 2123-2130.
|
| 12 |
钱桂生. 肺癌不同病理类型发病率的变化情况及其原因[J/CD]. 中华肺部疾病杂志(电子版), 2011, 4(1): 1-5.
|
| 13 |
Okimoto RA, Bivona TG. Recent advances in personalized lung cancer medicine[J]. Pers Med, 2014, 11(3): 309-321.
|
| 14 |
Jang M, Cai L, Udeani GO, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes[J]. Science, 1997, 275(5297): 218-220.
|
| 15 |
Llijie Ma, wangping Li, ruixuan Wang, et al. Resveratrol enhanced anticancer effects of cisplatin on non-small cell lung cancer cell lines by inducing mitochondrial dysfunction and cell apoptosis[J]. Int J Oncol, 2015, 47(4): 1460-1468.
|
| 16 |
Dang CV. MYC on the path to cancer[J]. Cell, 2012, 149(1): 22-35.
|
| 17 |
Meyer N, Penn LZ. Reflecting on 25 years with MYC[J]. Nat Rev Cancer, 2008, 8(12): 976-990.
|
| 18 |
Adhikary S, Eilers M. Transcriptional regulation and transformation by Myc proteins[J]. Nat Rev Mol Cell Biol, 2005, 6(8): 635-645.
|
| 19 |
George J, Lim JS, Jang SJ, et al. Comprehensive genomic profiles of small cell lung cancer[J]. Nature, 2015, 524(7563): 47-53.
|
| 20 |
Semenova EA, Nagel R, Berns A, et al. Origins, genetic landscape，and emerging therapies of small cell lung cancer[J]. Genes Dev, 2015, 29(14): 1447-1462.
|
| 21 |
Helfrich BA, Kim J, Gao DX, et al. Barasertib(AZD1152), a small molecule Aurora B inhibitor, inhibits the growth of SCLC cell lines in vitro and in vivo[J]. Mol Cancer Ther, 2016, 15(10): 2314-2322.
|
| 22 |
Malynn BA, de Alboran IM, O′Hagan RC, et al. N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation[J]. Genes Dev, 2000, 14(11): 1390-1399.
|
| 23 |
Di Giacomo S, Sollazzo M, Paglia S, et al. MYC, cell competition，and cell death in cancer[J]. Genes, 2017, 8(4): 668-679.
|
| 24 |
Lu Q, Hong W. Bcl2 enhances c-Myc-mediated MMP-2 expression of vascular smooth muscle cells[J]. Cell Signal, 2009, 21(7): 1054-1059.
|
| 25 |
Noujaim D, van Golen CM, van Golen KL, et al. N-Myc and Bcl-2 coexpression induces MMP-2 secretion and activation in human neuroblastoma cells[J]. Oncogene, 2002, 21(29): 4549-4557.
|
| 26 |
李王平，马李杰，潘 蕾，等. 白藜芦醇诱导小细胞肺癌H446细胞凋亡机制的研究[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(1): 15-23.
|
| 27 |
van Golen CM, Soules ME, Grauman AR, et al. N-Myc overexpression leads to decreased beta1 integrin expression and increased apoptosis in human neuroblastoma cells[J]. Oncogene, 2003, 22(17): 2664-2673.
|
| 28 |
van Golen CM, Castle VP, Feldman EL. IGF-I receptor activation and BCL-2 overexpression prevent early apoptotic events in human neuroblastoma[J]. Cell Death Differ, 2000, 7(7): 654-665.
|
| 29 |
Lee MW, Kim DS, Kim HR, et al. Inhibition of N-myc expression sensitizes human neuroblastoma IMR-32 cells expressing caspase-8 to TRAIL[J]. Cell Prolif, 2019, 52(3): e12577.
|
| 30 |
Lu KV, Jong KA, Rajasekaran AK, et al. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line[J]. Lab Invest, 2004, 84(1): 8-20.
|
| 31 |
Grotzer MA, Castelletti D, Fiaschetti G, et al. Targeting Myc in pediatric malignancies of the central and peripheral nervous system[J]. Curr Cancer Drug Targets, 2009, 9(2): 176-188.
|